Chengda Pharmaceuticals: Qianhai Shengtai plans to reduce its shareholding by 7.27%.

Chengda Pharmaceutical announced that shareholder Shenzhen Qianhai Shengtai Investment Enterprise, holding more than 5% of the company's shares, plans to reduce its holdings of the company's shares by no more than 11.0069 million shares from September 29, 2025 to December 28, 2025 through block trading or bulk trading methods, accounting for 7.27% of the total share capital after excluding the shares held in the repurchase account. The reduction price will be determined based on market price.